Argonaut Group, Inc. and PXRE Group Ltd. to Merge, New Entity Will Be Named Argo Group
14 Mars 2007 - 9:09PM
Business Wire
Argonaut Group, Inc. (NasdaqGS: AGII), a specialty underwriter, and
PXRE Group Ltd. (NYSE:PXT), a Bermuda-based property reinsurer,
announced today they have signed a definitive merger agreement and
that the combined entity will do business as Argo Group
International Holdings Limited (�Argo Group�). Argo Group will
become the Bermuda holding company for PXRE�s existing insurance
subsidiaries, Argonaut Group�s U.S. operations, and a newly formed
Bermuda reinsurer named Peleus Reinsurance Ltd. Argo Group will
trade on The NASDAQ Stock Market under Argonaut Group Inc.�s
existing ticker symbol AGII. Mark E. Watson III, president and
chief executive officer of Argonaut Group, Inc., will become the
president and chief executive officer of Argo Group, subject to
obtaining Bermuda regulatory approval. The Board of Directors for
Argo Group will consist of the nine directors currently serving for
Argonaut Group, Inc. and four directors from PXRE Group, Ltd., with
a chairman elected from the resulting 13-member group. Mark E.
Watson III, commenting on the transaction, said, �Argonaut Group�s
merger with PXRE is a natural progression in our long-term strategy
as a growing specialty underwriter. With combined assets exceeding
$5 billion and shareholder�s equity of approximately $1.3 billion,
plus operations based in Bermuda, the United States and Europe, we
believe Argo Group will be well positioned to develop and grow a
sustainable and profitable global business platform. We view this
transaction as a solid investment consistent with our goal of
securing the future for our shareholders and clients.� Jeffrey
Radke, president and chief executive officer of PXRE Group Ltd.,
said, �Today�s announcement represents the successful conclusion of
the strategic review initiated by PXRE last year. After extensive
evaluation of numerous alternatives by a special committee of
PXRE's Board of Directors, it became clear that the best
opportunity to maximize the value of PXRE's existing franchise for
its shareholders was through a combination with an established and
well diversified property and casualty company such as Argonaut
Group. With its financial strength and specialty focus, the new
Argo Group will be able to leverage PXRE's substantial assets,
international platform and reinsurance capabilities to their
fullest on behalf of its newly expanded shareholder base." PXRE�s
newly formed Class 3 Bermuda subsidiary, Peleus Reinsurance Ltd.,
(�Peleus Re�) will serve as the specialty reinsurance platform for
Argo Group and will be licensed to write business in Bermuda.
Barbara C. Bufkin will be leaving her position as senior vice
president, Corporate Business Development for Argonaut Group, Inc.,
to become the president of Peleus Re (subject to obtaining Bermuda
regulatory approval). Peleus Re is expected to be assigned a rating
by A.M. Best in the near future. The Board of Directors of each
company has unanimously approved the definitive merger agreement.
Under terms of the merger agreement, holders of Argonaut Group,
Inc. common stock will receive 6.4672 shares of Argo Group (f/k/a
PXRE Group, Ltd.) common stock in exchange for each share of
Argonaut Group, Inc. common stock. The exchange ratio is subject to
various adjustments pursuant to the terms of the merger agreement.
Upon closing of the transaction, approximately 73% of Argo Group�s
outstanding common stock will be owned by former holders of
Argonaut Group, Inc. common stock and approximately 27% will be
owned by former holders of PXRE Group�s common stock and
convertible voting preferred shares. Additionally, prior to the
closing of the transaction, Argonaut Group, Inc. expects to pay a
dividend of approximately $60 million to its common shareholders.
In connection with the merger, the holders of PXRE's outstanding
convertible voting preferred shares and convertible common shares
have agreed to convert such shares into common shares immediately
prior to the closing of the transaction and to vote in favor of the
transaction. In consideration of their consent to the transaction,
agreement to convert and to surrender their contractual rights and
protections including their receipt of dividends, PXRE has agreed
to reduce the conversion price of the convertible voting preferred
shares from $11.28 to $6.24, which will result in the issuance of
9.32 million PXRE common shares upon conversion. Completion of the
transaction is contingent upon customary closing conditions,
including the approvals of the common shareholders of PXRE and the
common shareholders of Argonaut Group, Inc., as well as various
regulatory approvals and notices. The transaction is expected to
close by the end of the third quarter of 2007. Argonaut Group, Inc.
and PXRE Group Ltd. will conduct a joint investor conference call
to discuss the merger at 9:00 a.m. ET on Thursday, March 15, 2007.
The conference call can be accessed by visiting the investor
relations section of Argonaut Group's Web page, which can be found
at www.argonautgroup.com, or PXRE Group�s Web page, which can be
found at www.pxre.com, or by telephone toll free at 800-659-2037,
passcode 60496582. The international dial-in number for the
conference call is 617-614-2713, passcode 60496582. A webcast
replay of the conference call will be available approximately one
hour after the call's completion on Argonaut Group's investor
relations Web page, or by telephone toll free at 888-286-8010,
passcode 56228008. If calling from abroad, please access the
conference call replay by dialing 617-801-6888, passcode 56228008.
Argonaut Group�s Board of Directors was advised by Bear, Stearns
& Co. Inc., Friedman, Billings, Ramsey & Co., Inc., and
LeBoeuf, Lamb, Greene & MacRae LLP. The special committee of
PXRE�s Board of Directors was advised by Keefe, Bruyette &
Woods, Inc. and Dewey Ballantine LLP. PXRE was advised by Sidley
Austin LLP. About Argonaut Group, Inc. Headquartered in San
Antonio, Argonaut Group, Inc. (NasdaqGS: AGII) is a national
underwriter of specialty insurance products in niche areas of the
property and casualty market, with $3.7 billion in assets. Argonaut
Group offers a full line of high quality products and services
designed to meet the unique coverage and claims handling needs of
businesses in three primary segments: Excess and Surplus Lines,
Select Markets, and Public Entity. Members of Argonaut Group
include Colony, Argonaut Specialty, Rockwood, Great Central,
Grocers Insurance, Trident, and Argonaut Insurance. Information on
Argonaut Group and its subsidiaries is available at
www.argonautgroup.com. About PXRE Group Ltd. PXRE - with operations
in Bermuda, Europe and the United States - provides reinsurance
products and services to a worldwide marketplace. PXRE�s primary
focus is providing property catastrophe reinsurance and
retrocessional coverage. PXRE also provides marine, aviation and
aerospace products and services. PXRE�s common shares trade on the
New York Stock Exchange under the symbol "PXT." Forward Looking
Statements Discussions made in this press release that are not
statements of historical fact (including statements that include
terms such as �will,� �may,� �should,� �believe,� �expect,�
�anticipate,� �estimate,� �intend,� and �plan�) are forward-looking
statements that involve risks and uncertainties. Any
forward-looking statement is not a guarantee of future performance
and actual results could differ materially from those contained in
the forward-looking information. Such forward-looking statements
include, but are not limited to, statements about the benefits of
the business combination transaction involving Argonaut and PXRE,
including future financial and operating results, the new company�s
plans, objectives, expectations and intentions and other statements
that are not historical facts. The following factors, among others,
could cause actual results to differ from those set forth in the
forward-looking statements: the ability to obtain regulatory
approvals of the transaction on the proposed terms and schedule;
the failure of Argonaut or PXRE to approve the transaction; the
risk that the businesses will not be integrated successfully;
competition and its effect on pricing; legislative and regulatory
changes affecting the operations of PXRE or Argonaut; change to the
United States tax code; downgrades of the insurance
financial-strength ratings assigned by the major ratings agencies
to Argonaut�s and PXRE�s operating subsidiaries and unfavorable
changes in economic and business conditions. Additional factors
that may affect future results are contained in Argonaut�s and
PXRE�s filings with the SEC, which are available at the SEC�s
website http://www.sec.gov. Argonaut and PXRE disclaim any
obligation to update and revise statements contained in these
materials based on new information or otherwise. Additional
Information The proposed merger will be submitted to shareholders
of PXRE and Argonaut for their consideration. Shareholders are
urged to read the joint proxy statement/prospectus regarding the
proposed merger when it becomes available because it will contain
important information. Shareholders will be able to obtain a free
copy of the joint proxy statement/prospectus, as well as other
filings containing information about PXRE and Argonaut, without
charge, at the Securities Exchange Commission�s Internet site
(www.sec.gov). You will also be able to obtain these documents,
free of charge, by accessing PXRE�s website (http://www.PXRE.com)
or Argonaut�s website (http://www.argonautgroup.com). Copies of the
joint proxy statement/prospectus and the filings with the
Securities and Exchange Commission that will be incorporated by
reference in the joint proxy statement/prospectus can also be
obtained, without charge, by directing a request to Mary Scavarda,
Argonaut Group, Inc., 10101 Reunion Place, Suite 500, San Antonio,
TX 78216, or Jamie Tully of Sard Verbinnen, 630 Third Avenue, New
York, NY 10017.
Pxre (NYSE:PXT)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
Pxre (NYSE:PXT)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025